Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma

L. F. Porrata, K. Rsitow, D. J. Inwards, S. M. Ansell, I. N. Micallef, P. B. Johnston, T. M. Habermann, T. E. Witzig, J. P. Colgan, G. S. Nowakowski, C. A. Thompson, S. N. Markovic

Research output: Contribution to journal › Article › peer-review

44 Scopus citations

Fingerprint

Dive into the research topics of 'Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences